THE WEEK AHEAD: GPS; SLV, GDX/GDXJ, XOP, IWM/RUT

EARNINGS:
GPS (37/82/17.0%) is really the only earnings announcement that interests me from a volatility contraction perspective. Pictured here is a September 18th skinny short strangle, which was paying 2.03 as of Friday close.
EXCHANGE-TRADED FUNDS SCREENED FOR IMPLIED >35% AND WHERE THE OCTOBER AT-THE-MONEY SHORT STRADDLE IS PAYING >10% OF STOCK PRICE:
SLV (50/61/17.4%)
GDX (22/47/14.1%)
XLE (21/37/11.6%)
GDXJ (19/55/16.7%)
EWZ (18/45/13.2%)
XOP (14/49/14.0%)
Juice as a function of stock price resides in SLV (17.4%), followed by GDXJ (16.7%), GDX (14.1%), and XOP (14.0%).
BROAD MARKET:
QQQ (23/28/8.2%)
IWM (23/29/8.4%)
EFA (17/21/5.6%)
SPY (16/22/5.8%)
IWM/RUT is where the premium is, relatively speaking, followed by the QQQ's.
DIVIDEND YIELDERS:
XLU (18/22/6.8%)
EWA (18/22/7.8%)
EWZ (18/45/13.2%)
IYR (17/22/6.9%)
EFA (16/22/5.6%)
SPY (16/22/5.8%)
HYG (15/13/3.3%)
TLT (14/16/4.6%)
EMB (11/10/2.8%)
Brazil ... again?!
GPS (37/82/17.0%) is really the only earnings announcement that interests me from a volatility contraction perspective. Pictured here is a September 18th skinny short strangle, which was paying 2.03 as of Friday close.
EXCHANGE-TRADED FUNDS SCREENED FOR IMPLIED >35% AND WHERE THE OCTOBER AT-THE-MONEY SHORT STRADDLE IS PAYING >10% OF STOCK PRICE:
SLV (50/61/17.4%)
GDX (22/47/14.1%)
XLE (21/37/11.6%)
GDXJ (19/55/16.7%)
EWZ (18/45/13.2%)
XOP (14/49/14.0%)
Juice as a function of stock price resides in SLV (17.4%), followed by GDXJ (16.7%), GDX (14.1%), and XOP (14.0%).
BROAD MARKET:
QQQ (23/28/8.2%)
IWM (23/29/8.4%)
EFA (17/21/5.6%)
SPY (16/22/5.8%)
IWM/RUT is where the premium is, relatively speaking, followed by the QQQ's.
DIVIDEND YIELDERS:
XLU (18/22/6.8%)
EWA (18/22/7.8%)
EWZ (18/45/13.2%)
IYR (17/22/6.9%)
EFA (16/22/5.6%)
SPY (16/22/5.8%)
HYG (15/13/3.3%)
TLT (14/16/4.6%)
EMB (11/10/2.8%)
Brazil ... again?!
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.